Shaomeng Wang

152PUBLICATIONS
212CO-AUTHORS
Separation technologiesBiologically active moleculesCardiology (incl. cardiovascular diseases)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (152)

|Jul 05, 2026
Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

|Jun 23, 2026
Discovery of SMD-6346: A Potent, Selective, and Orally Active SMARCA2 Degrader for Targeting SMARCA4-Deficient Human Cancers.

|Jun 16, 2026
Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity.

|Apr 15, 2026
Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX models.

|Mar 23, 2026
Discovery of SD-965 as a Potent, Selective, and Efficacious STAT3 PROTAC Degrader.

Dimin Wu, Haibin Zhou, Longchuan Bai

|Oct 15, 2025
RAS Mutation-Specific Responses to Paralog- and State-Selective RAS Inhibitors.

Beau Baars, Ana Orive-Ramos, Matthew J Emmett

Pageof 26

Frequent Collaborators

81 joint publications

Gunda I Georg

76 joint publications

Alanna Schepartz

76 joint publications

Kenneth M Merz

76 joint publications

Courtney C Aldrich